Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3115–3125. doi: 10.1167/iovs.06-1009

Table 7.

Increase or Decrease in Sensitivity at 94% Specificity with Adjusted Probability

Combination of Tests Overall Group 1 Strabismus Specificity
Year 1 (n = 346) (n = 139) (n = 448) (n = 796)
 NCR and CT 0.01 (0.87) 0.01 (0.87) 0.21 (0.008) 0.94
 Retinomax and CT 0.03 (0.40) 0.01 (0.87) 0.25 (0.008) 0.93
 Lea VA and CT 0.00 (0.87) 0.06 (0.80) 0.25 (0.008) 0.93
 HOTV VA and CT 0.13 (0.0006) 0.17 (0.0006) 0.31 (0.0008) 0.91
Year 2 (n = 409) (n = 172) (n = 62) (n = 1037)
 Retinomax and MTI 0.04 (0.14) 0.04 (0.39) 0.16 (0.04) 0.93
 SureSight and MTI 0.04 (0.23) 0.06 (0.19) 0.15 (0.10) 0.93
 Retinomax and Stereo Smile II −0.02 (0.23) 0.01 (0.55) 0.18 (0.009) 0.94
 SureSight and Stereo Smile II −0.03 (0.23) 0.03 (0.55) 0.07 (0.37) 0.94

Probabilities were adjusted using the Hochberg procedure for multiple comparisons. Changes significant at the P < 0.05 level are indicated in bold type.

94% specificity is not attainable.